Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …

The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …

The purpose of this statement is to describe and define the phenotypic abnormalities that
can be identified on visual and quantitative evaluation of computed tomographic (CT) …

Background: Patients with chronic obstructive pulmonary disease (COPD) often present with
severe acute exacerbations requiring hospital treatment. However, little is known about the …

Quantification of physical activities in daily life in patients with chronic obstructive pulmonary
disease has increasing clinical interest. However, detailed comparison with healthy subjects …

Background: Acute exacerbations (AEs) have a negative impact on various aspects of the
progression of COPD, but objective and detailed data on the impact of hospitalizations for an …

Background The mechanisms underlying chronic obstructive pulmonary disease (COPD)
remain unclear. MicroRNAs (miRNAs or miRs) are small non-coding RNA molecules that …

In patients with pulmonary disease, disease severity and prognosis are determined not only
by lung function impairment (1, 2). In patients with mild, moderate, or severe disease …

Aims To establish the prevalence of unrecognized heart failure in elderly patients with a
diagnosis of chronic obstructive pulmonary disease, in a stable phase of their disease …

Rationale: Chronic obstructive pulmonary disease (COPD) is associated with an increased
risk of cardiovascular events and osteoporosis. Increased arterial stiffness is an independent …